Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Heros Health vs Ivy Rx

Heros Health
Graded #190

Lower grade

vs+0.5
Ivy Rx
Graded #178

Higher grade

The verdict

Ivy Rx takes it — 66.8/100 to 66.3/100, but only just.

Ivy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering tiered compounded semaglutide and tirzepatide programs. Heros Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIvy Rx +2
60
62
Dose & formulationEven
64
64
Clinical oversightHeros Health +5
87
82
Labs & monitoringHeros Health +1
54
53
FulfillmentIvy Rx +5
76
81
Contract termsIvy Rx +6
49
55
Heros Health · left barIvy Rx · right bar

The numbers

MetricHeros HealthIvy Rx
WeighScore66.3/10066.8/100
GradeCC
Scorecard rank#190#178
Semaglutide$199/mo (compounded)$175/mo (starting dose, compounded)
Tirzepatide$199/mo (compounded)$275/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Heros Health

Graded #190 · C

Strengths

  • Compounded semaglutide and tirzepatide on a flat program price, not tiered by dose
  • Transparent pricing: $149 first month, then $199/mo (or $165/mo on the 3-month plan)
  • 90-day money-back guarantee on GLP-1 treatment
  • Dose adjustments at weeks 2, 4, and 8 included at no extra cost
  • Named board-certified physicians (Dr. Amber Patel, Dr. Scott Sanderson, Dr. Scott Nass)

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Specific 503A pharmacy partner is not named publicly
  • State coverage is stated inconsistently on the site (claims both 50 and 46 states)
  • No insurance billing — cash-pay only
Ivy Rx

Graded #178 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard